42882-36-0

Basic information

• Product Name: CHEMBRDG-BB 4014220
• Synonyms: CHEMBRDG-BB 4014220;AKOS JY2080587;N-BENZYL-2-METHYLPROPAN-1-AMINE;N-BENZYL-N-ISOBUTYLAMINE;UKRORGSYN-BB BBV-121332;N-benzyl-2-methylpropan-1-amine(SALTDATA: FREE)
• CAS NO: 42882-36-0
• Molecular Formula: C₁₁H₁₇N
• Molecular Weight: 163.262
• Mol File: 42882-36-0.mol
• Article Data: 26

Chemical Properties

• Boiling Point: 226.3°C at 760 mmHg
• Flash Point: 87.1°C
• Appearance: /
• Density: 0.902g/cm³
• Vapor Pressure: 0.0826mmHg at 25°C
• Refractive Index: 1.5
• Storage Temp.: 2-8°C(protect from light)
• PKA: 9.77±0.29(Predicted)
• CAS DataBase Reference: CHEMBRDG-BB 4014220(CAS DataBase Reference)
• NIST Chemistry Reference: CHEMBRDG-BB 4014220(42882-36-0)
• EPA Substance Registry System: CHEMBRDG-BB 4014220(42882-36-0)

Safety Data

• Hazardous Substances Data: 42882-36-0(Hazardous Substances Data)

Usage

General Description

CHEMBRDG-BB 4014220 is a chemical compound with the molecular formula C26H27N3O7S. It is a member of the benzodiazepine class of drugs, which are known for their sedative and anxiolytic effects. This particular compound has a molar mass of 521.57 g/mol and a heavy atom count of 37. It has not been analyzed extensively in the literature, but it may have potential pharmacological properties due to its structural similarity to other benzodiazepines. Further research and testing would be needed to fully understand its potential uses and effects.

InChI:InChI=1/C11H17N/c1-10(2)8-12-9-11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3

Upstream product

• 27845-49-4 benzylideneisobutylamine 
• 78-84-2 isobutyraldehyde 
• 932-90-1 Benzaldoxime 
• 100-46-9 benzylamine 
• 10294-56-1 phosphorous acid 
• 78-81-9 isobutylamine 
• 100-47-0 benzonitrile 
• 100-52-7 benzaldehyde 
• 766-08-5 methylphenylsilane 
• 84110-40-7 Dihydroxy-isobutyl-boran 
• 622-30-0 N-benzyl hydroxylalmine 
• 4774-58-7 N-benzylisobutyramide 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 

Downstream Products

• 100522-27-8 2-(benzyl-isobutyl-amino)-ethanol 
• 68723-28-4 N-methyl-N-benzylisobutylamine 
• 14165-26-5 N-Benzyl-N-isobutyl-aethylendiamin 
• 74732-51-7 N-benzyl-N-isobutyl-4-methylbenzenesulfonamide 
• 1213710-57-6 C₂₆H₃₈N₂O₃ 
• 111628-79-6 (S)-[3-Methyl-1-[[(2-methylpropyl)(phenylmethyl)amino]acetyl]butyl]carbamic acid, 1,1dimethylethyl ester, 4-methylbenzenesulfonic acid salt 

Relevant articles and documents

High-Fidelity Sequence-Selective Duplex Formation by Recognition-Encoded Melamine Oligomers

Melamine oligomers composed of repeating triazine-piperidine units and equipped with phenol and phosphine oxide side-chains form H-bonded duplexes. The melamine backbone provides sufficient rigidity to prevent intramolecular folding of oligomers up to thr

Continuous flow heterogeneous catalytic reductive aminations under aqueous micellar conditions enabled by an oscillatory plug flow reactor

Despite the fact that continuous flow processing exhibits well-established technical advances, aqueous micellar chemistry, a field that has proven extremely useful in shifting organic synthesis to sustainable water-based media, has mostly been explored under conventional batch-based conditions. This is particularly because of the fact that the reliable handling of slurries and suspensions in flow has been considered as a significant technical challenge. Herein, we demonstrate that the strategic application of an oscillatory plug flow reactor enables heterogeneous catalytic reductive aminations in aqueous micellar media enhancing mass transport and facilitating process simplicity, stability and scalability. The micellar flow process enabled a broad range of substrates, including amino acid derivatives, to be successfully transformed under reasonably mild conditions utilizing only very low amounts of Pd/C as a readily available heterogeneous catalyst. The preparative capabilities of the process along with the recyclability of the heterogenous catalyst and the aqueous reaction media were also demonstrated. This journal is

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.